Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cholinergic nervous system and glaucoma: From basic science to clinical applications
Muneeb A. Faiq, Gadi Wollstein, Joel S. Schuman, et al.
Progress in Retinal and Eye Research (2019) Vol. 72, pp. 100767-100767
Open Access | Times Cited: 106

Showing 1-25 of 106 citing articles:

Role of Cholinergic Signaling in Alzheimer’s Disease
Zhi-Ru Chen, Jiabao Huang, Shu‐Long Yang, et al.
Molecules (2022) Vol. 27, Iss. 6, pp. 1816-1816
Open Access | Times Cited: 384
Niosomal Drug Delivery Systems for Ocular Disease—Recent Advances and Future Prospects
Saliha Durak, Monireh Esmaeili Rad, Abuzer Alp Yetisgin, et al.
Nanomaterials (2020) Vol. 10, Iss. 6, pp. 1191-1191
Open Access | Times Cited: 143
The interplay of autophagy and oxidative stress in the pathogenesis and therapy of retinal degenerative diseases
Kun‐Che Chang, Pei‐Feng Liu, Chia‐Hsuan Chang, et al.
Cell & Bioscience (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 101
Updates on the Diagnosis and Management of Glaucoma
Isabella V. Wagner, Michael W. Stewart, Syril Dorairaj
Mayo Clinic Proceedings Innovations Quality & Outcomes (2022) Vol. 6, Iss. 6, pp. 618-635
Open Access | Times Cited: 73
The proteasome as a druggable target with multiple therapeutic potentialities: Cutting and non-cutting edges
Grazia R. Tundo, Diego Sbardella, Anna Maria Santoro, et al.
Pharmacology & Therapeutics (2020) Vol. 213, pp. 107579-107579
Open Access | Times Cited: 87
Chemical composition and acetylcholinesterase inhibitory potential, in silico, of Myrciaria floribunda (H. West ex Willd.) O. Berg fruit peel essential oil
Deyzi Caroline da Silva Barbosa, Vanderlan Nogueira Holanda, Caio Rodrigo Dias Assis, et al.
Industrial Crops and Products (2020) Vol. 151, pp. 112372-112372
Closed Access | Times Cited: 70
Spotlight on pyroptosis: role in pathogenesis and therapeutic potential of ocular diseases
Meini Chen, Rong Rong, Xiaobo Xia
Journal of Neuroinflammation (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 64
Glaucoma Clinical Research: Trends in Treatment Strategies and Drug Development
Line Hust Storgaard, Thuy Linh Tran, Josefine Freiberg, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 63
Addressing neurodegeneration in glaucoma: Mechanisms, challenges, and treatments
Ghazi O. Bou Ghanem, Lauren K. Wareham, David J. Calkins
Progress in Retinal and Eye Research (2024) Vol. 100, pp. 101261-101261
Open Access | Times Cited: 12
Mining and analysis of adverse event signals of Cariprazine based on the real-world data of FAERS database
Haohao Zhu, Yucai Qu, Zhiqiang Du, et al.
Journal of Affective Disorders (2023) Vol. 347, pp. 45-50
Closed Access | Times Cited: 20
Cytidine 5′-Diphosphocholine (Citicoline): Evidence for a Neuroprotective Role in Glaucoma
Stefano Gandolfi, Giorgio Marchini, Aldo Caporossi, et al.
Nutrients (2020) Vol. 12, Iss. 3, pp. 793-793
Open Access | Times Cited: 47
Can Treatment With Citicoline Eyedrops Reduce Progression in Glaucoma? The Results of a Randomized Placebo-controlled Clinical Trial
Luca Rossetti, Michele Iester, Laura Tranchina, et al.
Journal of Glaucoma (2020) Vol. 29, Iss. 7, pp. 513-520
Open Access | Times Cited: 41
Phenylalanine Metabolism Is Dysregulated in Human Hippocampus with Alzheimer’s Disease Related Pathological Changes
Pan Liu, Qian Yang, Ning Yu, et al.
Journal of Alzheimer s Disease (2021) Vol. 83, Iss. 2, pp. 609-622
Closed Access | Times Cited: 36
Determinants of approved acetylcholinesterase inhibitor response outcomes in Alzheimer’s disease: relevance for precision medicine in neurodegenerative diseases
Simone Lista, Andrea Vergallo, Stefan Teipel, et al.
Ageing Research Reviews (2022) Vol. 84, pp. 101819-101819
Open Access | Times Cited: 25
In vivo imaging of structural, metabolic and functional brain changes in glaucoma
Kevin C. Chan, Anisha Kasi, MuneebA Faiq
Neural Regeneration Research (2018) Vol. 14, Iss. 3, pp. 446-446
Open Access | Times Cited: 40
Altered DNA Methylation in the Developing Brains of Rats Genetically Prone to High versus Low Anxiety
Chelsea R. McCoy, Matthew E. Glover, Leigh T. Flynn, et al.
Journal of Neuroscience (2019) Vol. 39, Iss. 16, pp. 3144-3158
Open Access | Times Cited: 37
Widespread brain reorganization perturbs visuomotor coordination in early glaucoma
Vivek Trivedi, Ji Won Bang, Carlos Parra, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 37
Effect of Mindfulness Meditation on Intraocular Pressure and Trabecular Meshwork Gene Expression: A Randomized Controlled Trial
Tanuj Dada, Nithya Bhai, Neha Midha, et al.
American Journal of Ophthalmology (2020) Vol. 223, pp. 308-321
Closed Access | Times Cited: 36
Regulatory mechanisms of retinal ganglion cell death in normal tension glaucoma and potential therapies
Bingqing Huang, Jin Yang, Wencui Shen
Neural Regeneration Research (2022) Vol. 18, Iss. 1, pp. 87-87
Open Access | Times Cited: 19
The Role of Citicoline and Coenzyme Q10 in Retinal Pathology
Claudia García-López, Verónica García-López, José A. Matamoros, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5072-5072
Open Access | Times Cited: 11
Biochemical–molecular–genetic biomarkers in the tear film, aqueous humor, and blood of primary open-angle glaucoma patients
M.D. Pinazo-Durán, Vicente Zanón‐Moreno, Carolina García‐Villanueva, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 11
Pharmaceutical Approaches to Normal Tension Glaucoma
Maria Letizia Salvetat, Francesco Pellegrini, Leopoldo Spadea, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 8, pp. 1172-1172
Open Access | Times Cited: 11
Unveiling citicoline's mechanisms and clinical relevance in the treatment of neuroinflammatory disorders
Simona Cavalu, Sameh Saber, Asmaa Ramadan, et al.
The FASEB Journal (2024) Vol. 38, Iss. 17
Open Access | Times Cited: 4
Advances in Neuroprotection in Glaucoma: Pharmacological Strategies and Emerging Technologies
L. H. Wang, Chun-Hao Huang, I‐Chan Lin
Pharmaceuticals (2024) Vol. 17, Iss. 10, pp. 1261-1261
Open Access | Times Cited: 4
Antioxidants in Age-Related Macular Degeneration: Lights and Shadows
Uday Pratap Singh Parmar, Pier Luigi Surico, Takamasa Mori, et al.
Antioxidants (2025) Vol. 14, Iss. 2, pp. 152-152
Open Access
Page 1 - Next Page

Scroll to top